Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

被引：0
|
作者：
Timothy S. Bailey
Bruce W. Bode
Qianqian Wang
Alastair W. Knights
Annette M. Chang
机构：
[1] AMCR Institute,
[2] Atlanta Diabetes Associates Hospital,undefined
[3] Eli Lilly and Company,undefined
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Continuous glucose monitoring; Time in range; Type 2 diabetes; Ultra rapid lispro;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 897
页数：14
相关论文
共 50 条
  • [1] Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range
    Bailey, Timothy S.
    Bode, Bruce W.
    Wang, Qianqian
    Knights, Alastair W.
    Chang, Annette M.
    DIABETES THERAPY, 2023, 14 (05) : 883 - 897
  • [2] INCREASED TIME IN RANGE WITH ULTRA RAPID LISPRO (URLI) TREATMENT IN PARTICIPANTS WITH TYPE 2 DIABETES: PRONTO-TIME IN RANGE
    Wang, Q.
    Knights, A.
    Chang, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A193 - A194
  • [3] Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
    Malecki, Maciej T.
    Cao, Dachuang
    Liu, Rong
    Hardy, Thomas
    Bode, Bruce
    Bergenstal, Richard M.
    Bue-Valleskey, Juliana
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (11) : 853 - 860
  • [4] Ultra rapid lispro (URLi) improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D continuous glucose monitoring sub-study
    Malecki, M.
    Cao, D.
    Liu, R.
    Hardy, T. A.
    Bode, B. W.
    Bue-Valleskey, J. M.
    DIABETOLOGIA, 2019, 62 : S383 - S383
  • [5] Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes
    Bergenstal, Richard M.
    Bode, Bruce W.
    Bhargava, Anuj
    Wang, Qianqian
    Knights, Alastair W.
    Chang, Annette M.
    DIABETES THERAPY, 2023, 14 (11) : 1933 - 1945
  • [6] Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes
    Richard M. Bergenstal
    Bruce W. Bode
    Anuj Bhargava
    Qianqian Wang
    Alastair W. Knights
    Annette M. Chang
    Diabetes Therapy, 2023, 14 : 1933 - 1945
  • [7] Glycaemic control with Ultra Rapid Lispro (URLi) vs lispro in children and adolescents with type 1 diabetes: PRONTO-Peds
    Franco, D. R.
    Wadwa, R.
    Laffel, L. M.
    Dellva, M. A.
    Pollom, R. K.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S355 - S355
  • [8] Hybrid closed-loop with ultra-rapid insulin lispro increases time in range compared with standard insulin lispro in adults with type 1 diabetes: a randomised crossover study
    Lakshman, R.
    Nwokolo, M.
    Boughton, C. K.
    Ware, J.
    Allen, J. M.
    Wilinska, M. E.
    Alwan, H.
    Evans, M. L.
    Hovorka, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S388 - S389
  • [9] Efficacy and safety of ultra-rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO-Peds trial
    Wadwa, R. Paul
    Laffel, Lori M.
    Franco, Denise R.
    Dellva, Mary Anne
    Knights, Alastair W.
    Pollom, Robyn K.
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 89 - 97
  • [10] Ultra rapid lispro (URLi) improves postprandial glucose (PPG) control vs lispro in patients with type 2 diabetes: PRONTO-T2D study
    Frias, J. P.
    Zhang, Q.
    Blevins, T.
    Jinnouchi, H.
    Chang, A. M.
    DIABETOLOGIA, 2019, 62 : S384 - S384
12345